tiprankstipranks
Alzamend Neuro (ALZN)
NASDAQ:ALZN
US Market
ALZN
Alzamend Neuro
RESEARCH TOOLSreports

Alzamend Neuro (ALZN) Income Statement

397 Followers

Alzamend Neuro Income Statement

Last quarter (Q3 2026), Alzamend Neuro's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Alzamend Neuro's net income was $-2.20M. See Alzamend Neuro’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Apr 25Apr 24Apr 23Apr 22Apr 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -50.74K$ -50.74K$ -23.07K$ 0.00$ 0.00
Operating Expenses
$ 4.45M$ 9.94M$ 14.87M$ 12.32M$ 4.95M
Depreciation and Amortization
$ 50.74K$ 50.74K$ 23.07K$ 3.55K$ 4.95M
EBITDA
$ -4.45M$ -9.89M$ -14.85M$ -12.32M$ -4.95M
Operating Income
$ -4.50M$ -9.94M$ -14.87M$ -12.32M$ -4.95M
Other Income/Expenses
$ -18.03K$ -10.10K$ -7.70K$ -42.52K$ -94.68K
Pretax Income
$ -4.51M$ -9.95M$ -14.88M$ -12.36M$ -5.05M
Net Income
$ -4.51M$ -9.95M$ -14.88M$ -12.36M$ -5.05M
Per Share Metrics
Basic EPS
$ -11.32$ -132.33$ -205.97$ -187.31$ -93.78
Diluted EPS
$ -11.32$ -132.33$ -205.97$ -187.31$ -93.78
Weighted Average Shares Outstanding
 398.00K 75.00K 72.00K 65.00K 53.00K
Weighted Average Shares Outstanding (Diluted)
 450.80K 75.17K 72.24K 66.00K 53.81K
Currency in USD

Alzamend Neuro Earnings and Revenue History